Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485718 | SCV000565552 | likely benign | not provided | 2022-08-10 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ce |
RCV000485718 | SCV004130304 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | SERPINA3: PP3, BS1 |
Breakthrough Genomics, |
RCV000485718 | SCV005210845 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000019666 | SCV000039964 | pathogenic | ANTICHYMOTRYPSIN BONN 1 | 1993-09-04 | no assertion criteria provided | literature only | |
Prevention |
RCV003952363 | SCV004769689 | likely benign | SERPINA3-related disorder | 2023-05-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |